Recent negotiations between the distributor of cenobamate and the Pan Canadian Pharmaceutical Alliance which negotiates public access to new treatments on behalf of Canada’s Provincial and Territorial governments have broken off.
The patient voice is critical in letting our elected officials know that access to epilepsy therapies like Cenobamate are crucial for quality of life.
If you would like to help by writing a personal testimonial, volunteering to speak to the media or join a meeting with government decision makers, please contact info@canadianepilepsyalliance.org
